the single drop on one occasion and the infusion on another.
ml/min to the other eye (both solutions were at pH 7 2). On another occasion the treatments were -reversed. Measurements of intraocular pressure (IOP) and pupil diameter were made at 30 min intervals for 2 hours. The continuous infusion of dilute solution was as effective as the single drop of more concentrated solution in reducing IOP and in constricting the pupil; the drop was somewhat faster in producing its effect.
It has previously been shown in normal persons that the technique of continuous infusion of a dilute solution of pilocarpine at a rate which does not produce overflow from the conjunctival sac can be as effective as a pupilloconstrictor as a single drop of a more concentrated solution (Birmingham et al., 1976a) . We now report an investigation of the effectiveness of continuous infusion of dilute pilocarpine in lowering the intraocular pressurein elderly hospital outpatients with chronic simple glaucoma. A preliminary account of this work has been presented elsewhere (Birmingham et al., 1976b) .
Patients and methods
The subjects were 10 outpatients of the Glaucoma Clinic at Nottingham Eye Hospital who had a diagnosis of bilateral chronic simple glaucoma which was controlled by pilocarpine eye drops. There were 6 men and 4 women and their ages ranged from 63 to 83 years (mean 71 4 years). They gave their informed consent to participate in a comparison of the effect of a single drop of 2% pilocarpine at pH 7-2 with that of an infusion at 001 ml/min of 011% pilocarpine at pH 7 2. A cross-over design was used so that each eye received When a patient needed to move between rooms at i-hourly intervals for measurements of IOP and pupil diameter, the infusion was briefly interrupted and the syringe was temporarily removed from the syringe ram and clipped to the patient's clothing.
PILOCARPINE SOLUTIONS AND DOSES
The sterile solutions of pilocarpine hydrochloride were specially formulated to a pH of 7-2 by the addition of borate buffer. Owing to the much shorter shelf life of pilocarpine at near neutral pH than at its natural more acid pH (Riegelman and Vaughan, 1958; Cowle and Anderson, 1967 ) the solution was provided in 2 bottles, the contents of which were mixed immediately before use. One bottle contained the pilocarpine solution at its natural pH at twice the final concentration required, the other bottle contained an equal volume of an appropriate borate buffer and sodium chloride solution. On mixing the 2 solutions, a sterile solution, isotonic with tears, having a pH of 7-2 and pilocarpine concentration of 2% or 0-1% was obtained.
After the recording of baseline measurements the patients received one drop (0 05 ml) of 2% pilocarpine (dose 1 mg) to one eye and the infusion of 0-1% pilocarpine at 0-01 ml/min (dose 1 mg after 100 min) to the other eye. This procedure was reversed for the 2 eyes on the third visit.
The normal subjects received only the 0-104 pilocarpine infusion to the left eye on 1 occasion.
Results

COMPARISON OF THE OCULAR HYPOTENSIVE EFFECTS OF PILOCARPINE AT PH 7-2 GIVEN AS A SINGLE DROP OR AS AN INFUSION
The means of the 3 measurements of IOP made on both eyes when the 10 patients were on their usual treatment for their glaucoma were 18-8 mmHg for right eyes and 191 mmHg for left eyes (Table 1) . After stopping the treatment for 3 days, on 2 occasions at weekly intervals, the IOP rose in both eyes. The rise in pressure in the right eyes was. statistically significant; the rise in pressure in the left eyes was smaller and did not achieve statistical significance (Table 1) .
The single drop of 2% pilocarpine and the continuous infusion of 0O1% pilocarpine reduced the IOP of both eyes and the effect increased with time over the period of observation (Fig. 1) . At each 30 min point of measurement after the start of treatment the means of the differences between pretreatment measurements and post-treatment measurements for either the single drop or the continuous infusion were statistically significant (Table 2) . When the effects of the 2 treatments were compared, the degree of fall in pressure at each time of measurement was the same in the left eyes whether they had received the drop or the infusion. For the right eyes the fall in pressure was greater at 30 and at 60 mm for the drop compared with the infusion (this difference was statistically significant (Table 3) . When the treatments were compared, there was a significantly greater pupilloconstrictor effect from the drop than from the infusion in left eyes at 60 min only and in right eyes at 60 and at 90 min (notes a, b, and c, Table 3 ).
For the 5 normal subjects an infusion of 0-1 % pilocarpine to the left eye rapidly reduced pupil diameter to a mean of some 30% of control diameter by 50 min after the start of the infusion. This reduction persisted until the cessation of the infusion. Throughout the 120 min of infusion to the left eyes there was no change in diameter of the pupils of the untreated right eyes.
Discussion
From this comparison of 2 methods of administering pilocarpine the general conclusion seems to be that (Anderson and Cowle, 1968; Birmingham et al., 1976a) it was necessary to make the pH of both the concentrated drop and the dilute infusion the same (pH 7T2) at a value close to that of tears. It is unlikely that the patients' usual treatment was still exerting an effect 3 days after stopping the -,------i---, drops. Drance et al. (1974) showed that 15 h after 90 120 the high dose of a drop of 8% pilocarpine the IOP had returned to within 90% of the pre-drug value.
ressures of After stopping the usual treatment for 3 days the ic simple expected difference in pressure between the 2 eyes Xat recorded, was found. Davanger (1965) in an extensive study y preceding reported a mean difference in pressure between the oilocarpine 2 eyes of patients with glaucoma of 2-8 mmHg. In .1% solution the present small series the mean differences were atments were 3-4 mmHg at the second visit and 2-9 mmHg at the cond (lower third visit. effect of 2% pilocarpine to reach 'a steady state' at 75 min in 10 patients with glaucoma. Thus in the present investigation the effect of the infusion was compared at 2 hours with the likely maximal effect of the single drop. At the end of this 2 hour period the hypotensive effect of the 2 treatments was similar: in right eyes the mean falls in IOP were 817 mmHg for the infusion and 9-0 mmHg for the drop, in left eyes the corresponding values were 7-1 and 7T0 mmHg. The rate of achievement of this fall was greater for the drop than for the infusion in right eyes but the same in left eyes. Change in pupil diameter was measured as another index of entry of drug into the eye. Again the effect of the 2 treatments was similar at the end of 2 hours: in right eyes the mean pupilloconstrictor effects were 1N4 mm for the infusion and 1 6 mm for the drop, while the corresponding figures for left eyes were I1 and 1P3 mm. During the 2 hour period the greater effect of the drop at 60 min (both eyes) and at 90 min (right eyes only) suggests a faster rate of effect for the drop.
It is not surprising that there were some differences in the rate of onset of effect. Although the final dose at the end of 2 hours was the same, the initial concentration produced by the 2% drop would be higher than that produced by the 0-1% infusion. Schumacher (1966) found that pilocarpine (pH 4 2) could be detected in the aqueous of rabbits within 3-5 min of instillation of a single drop into the conjunctival sac. Van Hoose and Leaders (1974) suggested that the release of drug from the endothelial surface of the cornea depended on the concentration of the drug to which the cornea was exposed. The cornea was seen to act as a reservoir for the drug. The effectiveness of a 2% drop will decline after 2 hours (Drance and Nash, 1971) , whereas that of an infusion will continue for as long as the infusion is continued.
The observations on the time course of the effects of a single drop or an infusion on IOP and pupil diameter in patients with glaucoma are consistent with those for pupil diameter in normal subjects. Birmingham et al. (1976a) found the maximum effect of a single drop of 0-5% pilocarpine to be the same as that of an infusion of 0-01% pilocarpine but to occur 30 min earlier.
The study of the effects of administering pilocarpine to 1 eye showed that there was no detectable effect of that administration on the contralateral untreated eye. It seemed justifiable therefore to investigate different treatments to each of the 2 eyes on 1 occasion in the knowledge that there would be little or no interference between eyes.
We conclude from our results that a continuous infusion of a dilute solution of pilocarpine into the conjunctival sac is as effective in lowering the IOP in glaucoma as a more concentrated solution administered as a drop. The use of dilute solutions of pilocarpine would seem to be likely to reduce the possibility of systemic toxicity. To the advantage of the continuous maintenance by the infusion of an effective concentration in the eye for as long as the infusion is continued may be added the reduction in disturbance of the patient and the reduced nursing time compared with the frequent administration of drops. The principle of continuous infusion is obviously applicable to drugs other than pilocarpine. The use of a small body-borne infusion device allows the patient some degree of mobility during treatment (Bedford et al., 1976 
